Eidos Therapeutics
BioTech/Drugs - San Francisco, CA, US
Eidos Therapeutics Employees
Eidos Therapeutics Senior Management
Eidos Therapeutics Details
Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company's singular mission is to improve and prolong the lives of patients suffering from this disease.Launched in 2016 after years of research supported by Stanford's SPARK program, Eidos is led by a team of veteran biotechnology executives. Together with patients and physicians, the company aims to bring a safe, effective treatment to market as quickly as possible.
Website:
eidostx.com
Employees:
100 - 249
HQ:
415-887-1471
Location:
San Francisco, CA, US
Revenue:
10 - 20 Million
Eidos Therapeutics Technologies
Email Providers
Outlook
Load Balancers
Ubuntu
CMS
WP Engine
Hosting
Google Cloud Hosting
Search Marketing
Adobe Marketing Cloud